Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway

Hyunkyung Jeong, Dena E. Cohen, Libin Cui, Andrea Supinski, Jeffrey N. Savas, Joseph R. Mazzulli, John R. Yates, Laura Bordone, Leonard Guarente, Dimitri Krainc*

*Corresponding author for this work

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

Sirt1, a NAD-dependent protein deacetylase, has emerged as a key regulator of mammalian transcription in response to cellular metabolic status and stress. Here we show that Sirt1 has a neuroprotective role in models of Huntington's disease, an inherited neurodegenerative disorder caused by a glutamine repeat expansion in huntingtin protein (HTT). Brain-specific knockout of Sirt1 results in exacerbation of brain pathology in a mouse model of Huntington's disease, whereas overexpression of Sirt1 improves survival, neuropathology and the expression of brain-derived neurotrophic factor (BDNF) in Huntington's disease mice. We show that Sirt1 deacetylase activity directly targets neurons to mediate neuroprotection from mutant HTT. The neuroprotective effect of Sirt1 requires the presence of CREB-regulated transcription coactivator 1 (TORC1), a brain-specific modulator of CREB activity. We show that under normal conditions, Sirt1 deacetylates and activates TORC1 by promoting its dephosphorylation and its interaction with CREB. We identified BDNF as a key target of Sirt1 and TORC1 transcriptional activity in both normal and Huntington's disease neurons. Mutant HTT interferes with the TORC1-CREB interaction to repress BDNF transcription, and Sirt1 rescues this defect in vitro and in vivo. These studies suggest a key role for Sirt1 in transcriptional networks in both the normal and Huntington's disease brain and offer an opportunity for therapeutic development.

Original languageEnglish (US)
Pages (from-to)159-165
Number of pages7
JournalNature Medicine
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Huntington Disease
Chemical activation
Brain
Brain-Derived Neurotrophic Factor
Transcription
Mutant Proteins
Neurons
Proteins
Gene Regulatory Networks
Neuroprotective Agents
Pathology
Glutamine
Neurodegenerative Diseases
NAD
Modulators
mechanistic target of rapamycin complex 1
Neuroprotection
Defects
Huntingtin Protein

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Jeong, Hyunkyung ; Cohen, Dena E. ; Cui, Libin ; Supinski, Andrea ; Savas, Jeffrey N. ; Mazzulli, Joseph R. ; Yates, John R. ; Bordone, Laura ; Guarente, Leonard ; Krainc, Dimitri. / Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. In: Nature Medicine. 2012 ; Vol. 18, No. 1. pp. 159-165.
@article{38de5834694f4be98476471beca6132f,
title = "Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway",
abstract = "Sirt1, a NAD-dependent protein deacetylase, has emerged as a key regulator of mammalian transcription in response to cellular metabolic status and stress. Here we show that Sirt1 has a neuroprotective role in models of Huntington's disease, an inherited neurodegenerative disorder caused by a glutamine repeat expansion in huntingtin protein (HTT). Brain-specific knockout of Sirt1 results in exacerbation of brain pathology in a mouse model of Huntington's disease, whereas overexpression of Sirt1 improves survival, neuropathology and the expression of brain-derived neurotrophic factor (BDNF) in Huntington's disease mice. We show that Sirt1 deacetylase activity directly targets neurons to mediate neuroprotection from mutant HTT. The neuroprotective effect of Sirt1 requires the presence of CREB-regulated transcription coactivator 1 (TORC1), a brain-specific modulator of CREB activity. We show that under normal conditions, Sirt1 deacetylates and activates TORC1 by promoting its dephosphorylation and its interaction with CREB. We identified BDNF as a key target of Sirt1 and TORC1 transcriptional activity in both normal and Huntington's disease neurons. Mutant HTT interferes with the TORC1-CREB interaction to repress BDNF transcription, and Sirt1 rescues this defect in vitro and in vivo. These studies suggest a key role for Sirt1 in transcriptional networks in both the normal and Huntington's disease brain and offer an opportunity for therapeutic development.",
author = "Hyunkyung Jeong and Cohen, {Dena E.} and Libin Cui and Andrea Supinski and Savas, {Jeffrey N.} and Mazzulli, {Joseph R.} and Yates, {John R.} and Laura Bordone and Leonard Guarente and Dimitri Krainc",
year = "2012",
month = "1",
day = "1",
doi = "10.1038/nm.2559",
language = "English (US)",
volume = "18",
pages = "159--165",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "1",

}

Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. / Jeong, Hyunkyung; Cohen, Dena E.; Cui, Libin; Supinski, Andrea; Savas, Jeffrey N.; Mazzulli, Joseph R.; Yates, John R.; Bordone, Laura; Guarente, Leonard; Krainc, Dimitri.

In: Nature Medicine, Vol. 18, No. 1, 01.01.2012, p. 159-165.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway

AU - Jeong, Hyunkyung

AU - Cohen, Dena E.

AU - Cui, Libin

AU - Supinski, Andrea

AU - Savas, Jeffrey N.

AU - Mazzulli, Joseph R.

AU - Yates, John R.

AU - Bordone, Laura

AU - Guarente, Leonard

AU - Krainc, Dimitri

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Sirt1, a NAD-dependent protein deacetylase, has emerged as a key regulator of mammalian transcription in response to cellular metabolic status and stress. Here we show that Sirt1 has a neuroprotective role in models of Huntington's disease, an inherited neurodegenerative disorder caused by a glutamine repeat expansion in huntingtin protein (HTT). Brain-specific knockout of Sirt1 results in exacerbation of brain pathology in a mouse model of Huntington's disease, whereas overexpression of Sirt1 improves survival, neuropathology and the expression of brain-derived neurotrophic factor (BDNF) in Huntington's disease mice. We show that Sirt1 deacetylase activity directly targets neurons to mediate neuroprotection from mutant HTT. The neuroprotective effect of Sirt1 requires the presence of CREB-regulated transcription coactivator 1 (TORC1), a brain-specific modulator of CREB activity. We show that under normal conditions, Sirt1 deacetylates and activates TORC1 by promoting its dephosphorylation and its interaction with CREB. We identified BDNF as a key target of Sirt1 and TORC1 transcriptional activity in both normal and Huntington's disease neurons. Mutant HTT interferes with the TORC1-CREB interaction to repress BDNF transcription, and Sirt1 rescues this defect in vitro and in vivo. These studies suggest a key role for Sirt1 in transcriptional networks in both the normal and Huntington's disease brain and offer an opportunity for therapeutic development.

AB - Sirt1, a NAD-dependent protein deacetylase, has emerged as a key regulator of mammalian transcription in response to cellular metabolic status and stress. Here we show that Sirt1 has a neuroprotective role in models of Huntington's disease, an inherited neurodegenerative disorder caused by a glutamine repeat expansion in huntingtin protein (HTT). Brain-specific knockout of Sirt1 results in exacerbation of brain pathology in a mouse model of Huntington's disease, whereas overexpression of Sirt1 improves survival, neuropathology and the expression of brain-derived neurotrophic factor (BDNF) in Huntington's disease mice. We show that Sirt1 deacetylase activity directly targets neurons to mediate neuroprotection from mutant HTT. The neuroprotective effect of Sirt1 requires the presence of CREB-regulated transcription coactivator 1 (TORC1), a brain-specific modulator of CREB activity. We show that under normal conditions, Sirt1 deacetylates and activates TORC1 by promoting its dephosphorylation and its interaction with CREB. We identified BDNF as a key target of Sirt1 and TORC1 transcriptional activity in both normal and Huntington's disease neurons. Mutant HTT interferes with the TORC1-CREB interaction to repress BDNF transcription, and Sirt1 rescues this defect in vitro and in vivo. These studies suggest a key role for Sirt1 in transcriptional networks in both the normal and Huntington's disease brain and offer an opportunity for therapeutic development.

UR - http://www.scopus.com/inward/record.url?scp=84855563516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855563516&partnerID=8YFLogxK

U2 - 10.1038/nm.2559

DO - 10.1038/nm.2559

M3 - Article

VL - 18

SP - 159

EP - 165

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 1

ER -